{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:21:57Z","timestamp":1791105717298,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ejim.2012.04.010","type":"journal-article","created":{"date-parts":[[2012,5,12]],"date-time":"2012-05-12T11:01:51Z","timestamp":1336820511000},"page":"580-585","source":"Crossref","is-referenced-by-count":21,"title":["Antiplatelet treatment in primary and secondary stroke prevention in women"],"prefix":"10.1016","volume":"23","author":[{"given":"Valeria","family":"Caso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Santalucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Acciarresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Romana","family":"Pezzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Paciaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2012.04.010_bb0005","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/jnnp.51.11.1373","article-title":"A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981\u201386. 1. Methodology, demography and incident cases of first-ever stroke","volume":"51","author":"Bamford","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ejim.2012.04.010_bb0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2012.04.010_bb0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.STR.0000199613.38911.b2","article-title":"The lifetime risk of stroke: estimates from the Framingham Study","volume":"37","author":"Seshadri","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2012.04.010_bb0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/01.CIR.99.4.463","article-title":"Stroke in women: the 1997 Paul Dudley White International Lecture","volume":"99","author":"Bousser","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.04.010_bb0025","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1161\/01.STR.31.8.1833","article-title":"Sex differences and similarities in the management and outcome of stroke patients","volume":"31","author":"Holroyd-Leduc","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2012.04.010_bb0030","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/01.STR.0000157662.09551.e5","article-title":"Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network","volume":"36","author":"Kapral","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2012.04.010_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000082999","article-title":"Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial","volume":"24","author":"Niewada","year":"2005","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ejim.2012.04.010_bb0040","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1474-4422(08)70193-5","article-title":"Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes","volume":"7","author":"Reeves","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2012.04.010_bb0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCOUTCOMES.110.868307","article-title":"Representation of women in randomized clinical trials of cardiovascular disease prevention","volume":"3","author":"Melloni","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ejim.2012.04.010_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/STROKEAHA.107.493262","article-title":"Sex differences in acute stroke care in a statewide stroke registry","volume":"39","author":"Gargano","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2012.04.010_bb0055","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1161\/01.CIR.91.11.2742","article-title":"Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses","volume":"91","author":"Ajayi","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.04.010_bb0060","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00001721-200207000-00009","article-title":"Alterations in platelet function during the ovarian cycle","volume":"13","author":"Feuring","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ejim.2012.04.010_bb0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJM197807132990201","article-title":"A randomized trial of aspirin and sulfinpyrazone in threatened stroke. The Canadian Cooperative Study Group","volume":"299","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2012.04.010_bb0070","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2012.04.010_bb0075","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1373\/clinchem.2006.081059","article-title":"Determination of aspirin responsiveness by use of whole blood platelet aggregometry","volume":"53","author":"Ivandic","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejim.2012.04.010_bb0080","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.295.12.1420","article-title":"Sex differences in platelet reactivity and response to low-dose aspirin therapy","volume":"295","author":"Becker","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.04.010_bb0085","first-page":"335","article-title":"The A.I.C.L.A. controlled cooperative trial. Secondary prevention of cerebral ischemic accidents due to atherosclerosis by aspirin and dipyridamole. 3: Results","volume":"139","author":"Bousser","year":"1983","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.ejim.2012.04.010_bb0090","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2012.04.010_bb0095","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.04.010_bb0100","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.04.010_bb0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archinternmed.2011.628","article-title":"Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials","volume":"172","author":"Seshasai","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2012.04.010_bb0110","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/01.STR.0000083534.81284.C5","article-title":"Sex differences in management and outcome after stroke: a Swedish national perspective","volume":"34","author":"Glader","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2012.04.010_bb0115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF00193701","article-title":"Effects of triflusal and its main metabolite HTB on platelet interaction with subendothelium in healthy volunteers","volume":"47","author":"De La Cruz","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2012.04.010_bb0120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1365-2362.2000.00707.x","article-title":"A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function","volume":"30","author":"De Miguel","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2012.04.010_bb0125","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.STR.0000063141.24491.50","article-title":"Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial","volume":"34","author":"Matias-Guiu","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2012.04.010_bb0130","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1212\/01.WNL.0000113757.34662.AA","article-title":"Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study","volume":"62","author":"Culebras","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2012.04.010_bb0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.","volume":"321","author":"Hass","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2012.04.010_bb0140","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.289.22.2947","article-title":"Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial","volume":"289","author":"Gorelick","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.04.010_bb0145","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(89)92327-1","article-title":"The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke","volume":"1","author":"Gent","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.04.010_bb0150","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.04.010_bb0155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2217\/whe.11.20","article-title":"Secondary stroke prevention in women","volume":"7","author":"Acciarresi","year":"2011","journal-title":"Womens Health (Lond Engl)"},{"key":"10.1016\/j.ejim.2012.04.010_bb0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000076962","article-title":"Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data","volume":"17","author":"Diener","year":"2004","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.ejim.2012.04.010_bb0165","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2012.04.010_bb0170","first-page":"1351","article-title":"The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group","volume":"2","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.04.010_bb0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00001503-200404000-00013","article-title":"Management of trauma in the geriatric patient","volume":"17","author":"Deiner","year":"2004","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.ejim.2012.04.010_bb0180","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"Halkes","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.04.010_bb0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000222782","article-title":"Dipyridamole-associated headache in stroke patients\u2013interindividual differences?","volume":"62","author":"Lokk","year":"2009","journal-title":"Eur Neurol"},{"key":"10.1016\/j.ejim.2012.04.010_bb0190","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2012.04.010_bb0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.109.853069","article-title":"New P2Y(12) inhibitors","volume":"121","author":"Cattaneo","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.04.010_bb0200","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(11)60600-4","article-title":"Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial","volume":"377","author":"Bousser","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.04.010_bb0205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2012.04.010_bb0210","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart disease and stroke statistics\u20132011 update: a report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.04.010_bb0215","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2011.02.005","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in women\u20132011 update: a guideline from the American Heart Association","volume":"57","author":"Mosca","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2012.04.010_bb0220","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack. A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"62","author":"Furie","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2012.04.010_bb0225","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000131083","article-title":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008","volume":"25","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.ejim.2012.04.010_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620512000970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620512000970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T08:25:17Z","timestamp":1542961517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620512000970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0953620512000970"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2012.04.010","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}